| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Pharmacogenomic Testing for Psoriasis | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Diagnosis and Treatment of Sacroiliac Joint Pain | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Alpha1-Proteinase Inhibitors | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Romosozumab-aqqg (Evenity) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Enfortumab vedotin-ejfv (Padcev) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Allergy Immunotherapy | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Epcoritamab-bysp (Epkinly) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Gonadotropin Releasing Hormones (GnRHs) Analogs | 2026-01-12 |
| BCBS Highmark Penn Medicare Advantage | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-01-12 |